Pharma Journalist -

Enlivex Therapeutics Ltd. announced that an investigator-initiated multi-center Phase II clinical trial of AllocetraTM (formerly referred to as off-the-shelf AllocetraTM) in COVID-19…
Read More...

PTC Therapeutics, Inc. announced that it has entered into an agreement to acquire Censa Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of CNSA-001…
Read More...

Laurent Pharmaceuticals Inc., a Montreal-based biopharmaceutical company, announced that it has obtained the approval from Health Canada to initiate RESOLUTION, a Phase 2 randomized…
Read More...

AVROBIO, Inc. and Magenta Therapeutics announced a research and clinical collaboration agreement to evaluate the potential utility of MGTA-117, Magenta’s novel targeted antibody-drug…
Read More...

AGC Biologics has been selected to commercially manufacture the treatment Clevegen for partner Faron Pharmaceuticals Oy, a clinical stage biopharmaceutical company. Clevegen is a…
Read More...

Bicycle Therapeutics plc, a biotechnology company pioneering a new and differentiated class of therapeutics based on its proprietary bicyclic peptide (Bicycle) technology, announced…
Read More...

Alexion Pharmaceuticals, Inc. and Portola Pharmaceuticals, Inc. announced that they have entered into a definitive merger agreement for Alexion to acquire Portola, a commercial-stage…
Read More...

Today, the U.S. Food and Drug Administration approved Farxiga (dapagliflozin) oral tablets for adults with heart failure with reduced ejection fraction to reduce the risk of…
Read More...

Novartis announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion recommending the approval of Enerzair…
Read More...

Arcturus Therapeutics Holdings Inc. and Catalent, Inc. announced a partnership to support the expected manufacture of Arcturus’ COVID-19 mRNA vaccine candidate (LUNAR-COV19), intended…
Read More...